LykeShares
Chat Trending Shares
Sign up
Login
Sign Up
(current)
Top 10 Trends
Watchlist
Feedback
Advertise With Us
Profile
Home
Search
Top 10 Trends
Watchlist
Advertise
Feedback
Profile
Collegium Pharmaceutical Inc. Chat
+
Link
Image
Poll
G
Lykeshares
2y
Official
$PLL
Why Did Piedmont Sell Shares in Atlantic Lithium?
582 Views
1 Like
Reply
D
Lykeshares
2y
Official
$PCL
Why is Pancontinental Energy Permit Extension Important?
844 Views
1 Like
Reply
F
Lykeshares
2y
Official
$VMM
How Close Is Viridis Mining to Completing its Phase I & II Drilling?
436 Views
1 Like
Reply
C
Lykeshares
2y
Official
$EUR
Why Is European Lithium In a Trading Halt?
616 Views
2 Likes
Reply
C
Lykeshares
2y
Official
$ADN
Where Will Andromeda's Kaolin Products Be Distributed Under the New Sales Agreement?
369 Views
1 Like
Reply
S
Lykeshares
2y
Official
$AVZ
What Are the Key Details of AVZ Minerals' Legal Victory in the ICSID Arbitration?
1.3k Views
2 Likes
Reply
M
Lykeshares
2y
Official
$SYR
How Much of Syrah Resources Do the Directors Own?
471 Views
1 Like
Reply
C
Lykeshares
2y
Official
$LLL
How Has Leo Lithium Progressed at the Goulamina Lithium Project in Q4 2023?
452 Views
1 Like
Reply
T
Lykeshares
2y
Official
$NHE
Who Are the Biggest Share Holders of Noble Helium?
850 Views
2 Likes
Reply
A
Lykeshares
2y
Official
$QTWO
Who Is Alicia Milne? The CEO, President, and Director of Q2 Metals Corp
403 Views
1 Like
Reply
S
Lykeshares
2y
Official
$LLI
How Significant Is the Lithium Discovery For Loyal Lithium?
428 Views
1 Like
Reply
M
Lykeshares
2y
Official
$WA1
How Will the A$40 Million Raised by WA1 Resources Develop the West Arunta Project?
565 Views
1 Like
Reply
G
Lykeshares
2y
Official
$IXR
How Does Ionic Rare Earths' Mining Licence Grow the Business?
454 Views
1 Like
Reply
D
Lykeshares
2y
Official
$EXR
What Makes Elixir Energy's Daydream-2 Well in Queensland a Groundbreaking Discovery?
455 Views
1 Like
Reply
F
Lykeshares
2y
Official
$WA1
How Is WA1 Resources Using the A$15m Placement?
473 Views
1 Like
Reply
Loading…
NASDAQ:COLL — Live Chart, Financials & Chat | Collegium Pharmaceutical Inc.
C
Collegium Pharmaceutical Inc.
NASDAQ:COLL
United States
Revenue: 707m
$0.0/sec
Add to Watchlist
by TradingView